Fibroblast growth factor receptor inhibitors for non-muscle-invasive bladder cancer: THOR-2 and beyond

Albert Jang, Beaux Mitchell, Jason R. Brown, Vadim S. Koshkin

Open source

DOI
10.21037/tau-2026-0649
Published
2026-10
Container
Translational Andrology and Urology
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tau-2026-0649,
  title = {Fibroblast growth factor receptor inhibitors for non-muscle-invasive bladder cancer: THOR-2 and beyond},
  author = {Albert Jang and Beaux Mitchell and Jason R. Brown and Vadim S. Koshkin},
  year = {2026},
  journal = {Translational Andrology and Urology},
  doi = {10.21037/tau-2026-0649},
  url = {https://doi.org/10.21037/tau-2026-0649}
}

RIS

TY  - JOUR
TI  - Fibroblast growth factor receptor inhibitors for non-muscle-invasive bladder cancer: THOR-2 and beyond
AU  - Albert Jang
AU  - Beaux Mitchell
AU  - Jason R. Brown
AU  - Vadim S. Koshkin
PY  - 2026
JO  - Translational Andrology and Urology
DO  - 10.21037/tau-2026-0649
UR  - https://doi.org/10.21037/tau-2026-0649
ER  - 

APA

Jang, A., Mitchell, B., Brown, J. R., & Koshkin, V. S. (2026). Fibroblast growth factor receptor inhibitors for non-muscle-invasive bladder cancer: THOR-2 and beyond. Translational Andrology and Urology. https://doi.org/10.21037/tau-2026-0649

Source records